Terf2ip deficiency accelerates non-alcoholic steatohepatitis through regulating lipophagy and fatty acid oxidation via Sirt1/AMPK pathway

CONCLUSIONS: These results revealed that Terf2ip played a protective role in the progression of NASH through regulating lipophagy and FAO by binding to Sirt1 promoter. Our findings provided a potential therapeutic target for the treatment of NASH.PMID:38697492 | DOI:10.1016/j.freeradbiomed.2024.04.238
Source: Free Radical Biology and Medicine - Category: Biology Authors: Source Type: research